Cannabinoid Biosynthesis Market Size Worth USD 47.18 billion, Globally, By 2030 At 16.50% CAGR.

The latest market report published by Credence Research, Inc. “Global Cannabinoid Biosynthesis Market: Growth, Future Prospects, and Competitive Analysis, 2022 – 2030. The global cannabinoid biosynthesis market has experienced consistent growth in recent years and is projected to maintain a compound annual growth rate (CAGR) of 16.50% from 2023 to 2030. In 2022, the market was valued at USD 16.2 billion, and it is anticipated to reach USD 47.18 billion by 2030.

Cannabinoid Biosynthesis Market represents a pioneering segment within the biotechnology and pharmaceutical sectors, focusing on the production of cannabinoids through biological processes rather than traditional plant-based extraction. Cannabinoids, the active compounds found in cannabis plants, have garnered significant attention due to their potential therapeutic benefits in conditions like pain, epilepsy, and various neurodegenerative diseases. However, producing cannabinoids through cannabis cultivation can be resource-intensive, inconsistent, and subjected to regulatory limitations. As a solution, scientists are leveraging techniques in synthetic biology to produce cannabinoids in microbial hosts, such as yeast or bacteria, ensuring a consistent, scalable, and potentially more environmentally friendly production process.

Cannabinoid biosynthesis market dynamics in recent years have been characterized by a remarkable surge in research and development activities within the pharmaceutical and biotechnology sectors. As scientists continue to unlock the therapeutic potential of cannabinoids, there is an increased focus on developing efficient and scalable methods for their production. This has paved the way for significant advancements in cannabinoid biosynthesis techniques, including genetically modified organisms (GMOs), hemp cultivation optimization, and innovative extraction processes. The rise of synthetic biology tools such as gene editing technologies has enabled researchers to manipulate biosynthetic pathways, leading to the production of targeted cannabinoids with enhanced potency and purity. Moreover, increasing legalization efforts around cannabis for medicinal purposes across several regions have generated immense interest from investors looking to capitalize on this emerging market.

List of the prominent players:

  • Amyris, Inc.
  • Willow Bioscience Inc.
  • Cronos Group
  • Zymergen Inc.
  • Constellation Brands, Inc.
  • Jazz Pharmaceuticals plc
  • Canopy Growth Corporation
  • InMed Pharmaceuticals Inc.
  • Hyasynth Biologicals Inc.
  • Renew Biopharma, Inc.

Browse 243 pages report Cannabinoid Biosynthesis Market By Application (Anxiety and Pain Management, Nausea Treatment, Appetite Stimulation) – Growth, Future Prospects & Competitive Analysis, 2016 – 2030)-

Cannabinoid Biosynthesis Market Key Offerings-

Biosynthetic Cannabinoids: Production of primary cannabinoids like THC (tetrahydrocannabinol), CBD (cannabidiol), and CBG (cannabigerol) using microbial hosts, ensuring high purity and consistency.

Rare Cannabinoid Production: Unlike traditional extraction, biosynthesis allows for the production of less abundant cannabinoids such as CBC (cannabichromene), CBN (cannabinol), and THCV (tetrahydrocannabivarin), among others.

Customization & Scalability: Companies offer the ability to tailor the production process to yield specific cannabinoid profiles and can rapidly scale production in response to demand.

Research & Development Services: Some companies provide R&D services to develop proprietary strains or processes for cannabinoid production, including metabolic engineering and pathway optimization.

Enzymes and Intermediates: Companies may offer specific enzymes or intermediary compounds essential for the biosynthesis pathway, aiding in the efficient production of cannabinoids.

Strain Development: Creating and optimizing microbial strains (like yeast or bacteria) tailored for efficient cannabinoid production.

Licensing & Technology Transfer: Given the proprietary nature of some of the technologies involved, companies may license their technology or methodologies to other producers or researchers.

Consulting and Technical Services: Expertise in the cannabinoid biosynthesis process, equipment setup, quality control, and regulatory compliance, guiding other businesses in establishing or optimizing their production.

Quality Assurance & Control Tools: Solutions that ensure the produced cannabinoids meet the desired purity and potency criteria, essential for medical-grade products.

End-to-end Production Solutions: Some companies might offer comprehensive solutions that cover the entire spectrum of cannabinoid biosynthesis, from strain development to final product extraction and purification.

Cannabinoid Biosynthesis Market Future Outlook-

The future of the Cannabinoid Biosynthesis Market appears remarkably promising, riding on the cusp of biotechnological advancements and the ever-increasing demand for pure and consistent cannabinoids. As the therapeutic potential of both major and minor cannabinoids continues to unfold, the need for scalable, sustainable, and precise production methods will only intensify. The convergence of synthetic biology with advanced analytics, artificial intelligence, and automation will likely usher in a new era of innovation in the biosynthesis space, making the production process even more efficient and cost-effective.

Regulatory environments are expected to evolve, further legitimizing and standardizing the sector, which will bolster investor confidence and facilitate market expansion. Additionally, the potential for producing rare cannabinoids through biosynthesis will open new avenues for medical research and therapeutic applications, diversifying the market’s product portfolio. Strategic collaborations, mergers, and acquisitions will shape the competitive landscape, fostering rapid technology transfer, and market penetration. In essence, the Cannabinoid Biosynthesis Market is on track to revolutionize the supply chain of cannabinoids, positioning itself as a pivotal player in the global cannabis industry’s future.

Why to Buy This Report-

  • The report provides a qualitative as well as quantitative analysis of the global Cannabinoid Biosynthesis Market by segments, current trends, drivers, restraints, opportunities, challenges, and market dynamics with the historical period from 2016-2020, the base year- 2021, and the projection period 2022-2028.
  • The report includes information on the competitive landscape, such as how the market’s top competitors operate at the global, regional, and country levels.
  • Major nations in each region with their import/export statistics
  • The global Cannabinoid Biosynthesis Market report also includes the analysis of the market at a global, regional, and country-level along with key market trends, major players analysis, market growth strategies, and key application areas.

Browse Full Report:


Related Report:

Related Report:

Browse Our Blog:

Browse Our Blog:

About Us –

Credence Research is a viable intelligence and market research platform that provides quantitative B2B research to more than 10,000 clients worldwide and is built on the Give principle. The company is a market research and consulting firm serving governments, non-legislative associations, non-profit organizations, and various organizations worldwide. We help our clients improve their execution in a lasting way and understand their most imperative objectives. For nearly a century, we’ve built a company well-prepared for this task.

Contact Us:

Office No 3 Second Floor, Abhilasha Bhawan, Pinto Park, Gwalior [M.P] 474005 India

Leave a Reply

Your email address will not be published.